Breast cancer remains the number one diagnosed cancer in women in the United States, other than skin cancer, according to the American ... and they don't produce much of the protein HER2. These ...

The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.

Dr. Erika Hamilton discusses the most notable breast cancer treatments currently in development, and how might they change ...

Preliminary results of an observational clinical trial underway at Roswell Park Comprehensive Cancer Center are shedding ...

The Cancer Immunotherapy market, valued at USD 220.94 billion in 2024, is expected to register robust revenue CAGR of 13.6%.

After sharing her breast cancer diagnosis in 2024, Olivia Munn shared that her mother Kim Munn went through her own battle ...

Estrogen-progestin hormone therapy used to manage menopausal symptoms and other women’s health conditions is associated with ...

HER-2-low breast cancer is a subset within HER2-negative disease, which is still undergoing active research to find the optimal ways to detect and treat it.

Thousands of women battling advanced breast cancer could be denied access to crucial life-extending medication due to an "unfair" assessment process for NHS drug approval. At such a critical moment in ...

Ric Flair has shared some photos and asked for prayers ahead of his upcoming cancer surgery. The Nature Boy revealed recently that he had been diagnosed with skin cancer for the second time in ...

Upper GI cancer treatment depends on a number of factors, and may include treatments such as surgery, chemotherapy, radiation ...

Rates of HER2 expression are examined and trastuzumab is tested in combination with paclitaxel and carboplatin in patients with resistant advanced ovarian cancer.